Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016-Reference-Cited by-同舟云学术

Safety profiles of percutaneous left atrial appendage closure devices: An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016

Published:2017-11-01 Issue:1 Volume:29 Page:5-13
ISSN:1045-3873
Container-title:Journal of Cardiovascular Electrophysiology
language:en
Short-container-title:J Cardiovasc Electrophysiol

Author:

Jazayeri Mohammad-Ali¹^ORCID,Vuddanda Venkat¹,Turagam Mohit K.²,Parikh Valay¹,Lavu Madhav¹,Atkins Donita¹,Earnest Matthew¹³,Di Biase Luigi⁴^ORCID,Natale Andrea⁵^ORCID,Wilber David⁶,Reddy Yeruva Madhu¹³,Lakkireddy Dhanunjaya R.¹³^ORCID

Affiliation:

1. Division of Cardiovascular Diseases, Cardiovascular Research Institute; University of Kansas Hospital & Medical Center; Kansas City KS USA

2. Division of Cardiovascular Disease; University of Missouri Hospital & Clinics; Columbia MO USA

3. Mid-America Cardiology, Bloch Heart Rhythm Center; University of Kansas Hospital & Medical Center; Kansas City KS USA

4. Electrophysiology Section; Albert Einstein College of Medicine at Montefiore Medical Center; Bronx NY USA

5. Texas Cardiac Arrhythmia Institute at St. David's Medical Center; Austin TX USA

6. Division of Cardiovascular Medicine; Loyola University Medical Center; Chicago IL

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jce.13362/fullpdf

Reference34 articles.

1. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study;Go;JAMA,2001

2. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence;Miyasaka;Circulation,2006

3. Atrial fibrillation as an independent risk factor for stroke: The Framingham study;Wolf;Stroke,1991

4. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society;January;J Am Coll Cardiol,2014

5. Why do patients with atrial fibrillation not receive warfarin;Bungard;Arch Intern Med,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Reproducibility of Research Based on the Food and Drug Administration Manufacturer and User Facility Device Experience Data;Journal of Patient Safety;2024-03-13

2. LARIAT or AtriClip: Complications Profile and Comparison in Patients with Atrial Fibrillations Based on Manufacturer and User Facility Device Experience Database;Medicina;2023-11-21

3. Follow Up imaging After Left Atrial Appendage Occlusion–Something or Nothing and for How Long?;Cardiac Electrophysiology Clinics;2023-06

4. Left Atrial Appendage Occlusion: Current and Future;Atrial Fibrillation - Diagnosis and Management in the 21st Century;2022-11-30

5. Adverse Events Associated With Robotic-Assisted Joint Arthroplasty: An Analysis of the US Food and Drug Administration MAUDE Database;The Journal of Arthroplasty;2022-08